Industry Overview
Pharmaceutical companies face commodity exposure through petrochemical feedstocks used in drug synthesis, energy costs for manufacturing facilities, and precious metal catalysts (particularly platinum group metals) in chemical reactions. Natural gas is both an energy source and a feedstock for nitrogen-based pharmaceutical intermediates. Rising energy costs can squeeze margins, though the industry's pricing power and high margins provide significant insulation compared to other manufacturing sectors.
Commodity Exposure
Key Companies
Related ETFs
XLV (Health Care Select Sector SPDR)
IBB (iShares Biotechnology ETF)